Ocugen Inc (OCGN)
1.59
-0.08
(-4.79%)
USD |
NASDAQ |
May 10, 16:00
1.65
+0.06
(+3.77%)
After-Hours: 04:11
Ocugen SG&A Expense (Quarterly): 5.155M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.155M |
September 30, 2023 | 9.082M |
June 30, 2023 | 9.564M |
March 31, 2023 | 8.193M |
December 31, 2022 | 7.226M |
September 30, 2022 | 7.497M |
June 30, 2022 | 10.56M |
March 31, 2022 | 10.12M |
December 31, 2021 | 7.47M |
September 30, 2021 | 4.508M |
June 30, 2021 | 6.757M |
March 31, 2021 | 4.185M |
December 31, 2020 | 2.214M |
September 30, 2020 | 1.704M |
June 30, 2020 | 1.779M |
March 31, 2020 | 2.277M |
December 31, 2019 | 2.532M |
September 30, 2019 | 1.408M |
June 30, 2019 | 2.614M |
March 31, 2019 | 2.929M |
December 31, 2018 | 2.145M |
Date | Value |
---|---|
September 30, 2018 | 2.426M |
June 30, 2018 | 2.826M |
March 31, 2018 | 2.807M |
December 31, 2017 | 2.667M |
September 30, 2017 | 2.225M |
June 30, 2017 | 2.166M |
March 31, 2017 | 2.326M |
December 31, 2016 | 2.389M |
September 30, 2016 | 1.768M |
June 30, 2016 | 2.161M |
March 31, 2016 | 2.212M |
December 31, 2015 | 2.231M |
September 30, 2015 | 2.191M |
June 30, 2015 | 1.735M |
March 31, 2015 | 2.109M |
December 31, 2014 | 1.722M |
September 30, 2014 | 1.703M |
June 30, 2014 | 1.341M |
March 31, 2014 | 1.799M |
December 31, 2013 | 1.917M |
September 30, 2013 | 0.75M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.408M
Minimum
Sep 2019
10.56M
Maximum
Jun 2022
5.518M
Average
5.155M
Median
Dec 2023
SG&A Expense (Quarterly) Benchmarks
QuidelOrtho Corp | 187.60M |
Johnson & Johnson | 5.057B |
Akebia Therapeutics Inc | 25.44M |
Shockwave Medical Inc | 103.72M |
iBio Inc | 2.961M |